| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $853K | +1519.3% |
| Gross Profit | $853K | +1519.3% |
| R&D Expense | $703 | +0.0% |
| SG&A Expense | $1.4M | -37.7% |
| Operating Income | -$561K | +74.8% |
| Pre-tax Income | -$534K | +76.5% |
| Net Income | -$534K | +76.5% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124 | — |
| Accounts Receivable | $1.1M | +3775.4% |
| Current Assets | $1.2M | +1759.2% |
| Total Assets | $1.5M | +28.3% |
| Current Liabilities | $1.6M | +55.1% |
| Total Liabilities | $1.8M | +48.2% |
| Stockholders' Equity | -$258K | -1444.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$406K | +49.7% |
| Investing Cash Flow | -$22K | +0.0% |
| Financing Cash Flow | $406K | -34.9% |